Repositorio de producción científica de la Universidad de Sevilla

A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae

 

Advanced Search
 
Opened Access A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae
Cites

Show item statistics
Icon
Export to
Author: Pascual Hernández, Álvaro
Rodríguez-Baño, Jesús
Martínez Martínez, Luis
Cueto López, Marina de
Department: Universidad de Sevilla. Departamento de Microbiología
Universidad de Sevilla. Departamento de Medicina
Date: 2016-07-01
Published in: Antimicrobial Agents and Chemotherapy, 60 (7), 4159-4169.
Document type: Article
Abstract: The spread of extended-spectrum-β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) is leading to increased carbapenem consumption. Alternatives to carbapenems need to be investigated. We investigated whether β-lactam/β-lactamase inhibitor (BLB...
[See more]
Cite: Pascual Hernández, Á., Rodríguez Baño, J., Martínez Martínez, L. y Cueto López, M. (2016). A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae. Antimicrobial Agents and Chemotherapy, 60 (7), 4159-4169.
Size: 850.9Kb
Format: PDF

URI: http://hdl.handle.net/11441/64065

DOI: 10.1128/AAC.00365-16

See editor´s version

This work is under a Creative Commons License: 
Attribution-NonCommercial-NoDerivatives 4.0 Internacional

This item appears in the following Collection(s)